Image de couverture de livre

Contraindicated psychotropic medication use widespread

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteur principal:	Alison Knopf
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	The Brown University Child & Adolescent Psychopharmacology Update
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Medical groups issue joint statement on psychotropic safety
par: Alison Knopf
Publié: (2025)

New ADHD medication on the horizon
par: Alison Knopf
Publié: (2026)

HHS critical of “overprescribing” psychiatric medications to children
par: Alison Knopf
Publié: (2026)

HHS criticizes many psychiatric medications for youth
par: Alison Knopf
Publié: (2025)

ADHD medications with fewer adverse events would improve outcomes
par: Alison Knopf
Publié: (2024)

Researchers: Opioid treatment medications only work if patients take them
par: Alison Knopf
Publié: (2026)

Why a complete medical exam is necessary prior to diagnosing ADHD
par: Alison Knopf
Publié: (2024)

Many youths with depression do not receive quality medication care: Study
par: Alison Knopf
Publié: (2025)

Prenatal use of benzodiazepines associated with preterm birth
par: Alison Knopf
Publié: (2026)

Research and clinical use of transcranial magnetic stimulation
par: Alison Knopf
Publié: (2024)

Prescribe for patients with opioid use disorder — with confidence
par: Alison Knopf
Publié: (2024)

Parental substance use and violent behavior by their children
par: Alison Knopf
Publié: (2025)

Externalizing problems and concurrent use of cannabis and tobacco
par: Alison Knopf
Publié: (2024)

Substance use screening urged in EDs for youth in crisis
par: Alison Knopf
Publié: (2026)

Treatments needed for young people with stimulant use disorders
par: Alison Knopf
Publié: (2025)

Screen time associated with substance use in young adolescents
par: Alison Knopf
Publié: (2024)

Prenatal cannabis use linked to adverse birth outcomes
par: Alison Knopf
Publié: (2025)

Substance use by teens stays low: MTF study
par: Alison Knopf
Publié: (2025)

Stimulant prescribing up among teens, but nonmedical use down
par: Alison Knopf
Publié: (2025)

Addictive screen use common in teens, linked to suicidal behaviors
par: Alison Knopf
Publié: (2025)

Dopamine link between psychosis and cannabis use disorder unclear
par: Alison Knopf
Publié: (2025)

Literature review: Melatonin use by young children should be reduced or prevented
par: Alison Knopf
Publié: (2026)

Link between cannabis use and schizophrenia is likely causal, especially for teens
par: Alison Knopf
Publié: (2025)

Researchers consider links between genetics and psychosis in teen use of psychedelics
par: Alison Knopf
Publié: (2024)

Researchers find maternal use of ADHD stimulants safe during pregnancy
par: Alison Knopf
Publié: (2024)

Youth e‐cigarette use drops to recent low level: Good news
par: Alison Knopf
Publié: (2024)

To find out how social media use affects teens, look at depression/anxiety
par: Alison Knopf
Publié: (2024)

NIDA: More than 11% of high school seniors use delta‐8, the unregulated THC
par: Alison Knopf
Publié: (2024)

Methylphenidate for ADHD found to have effects on stature and BMI
par: Alison Knopf
Publié: (2026)

Assess the family to help the child – and the family
par: Alison Knopf
Publié: (2026)

Teens with close families less likely to be lonely adults
par: Alison Knopf
Publié: (2026)

Psychopathology risk in mid‐adolescence increased by multiple prenatal adversities
par: Alison Knopf
Publié: (2026)

Loneliness in early adolescence associated with increased risk for mental disorders
par: Alison Knopf
Publié: (2026)

NY takes steps to rein in youth gambling
par: Alison Knopf
Publié: (2026)

International group adds new items focusing on pediatrics in trials
par: Alison Knopf
Publié: (2026)

Study suggests glutamate receptor may help differentiate autism varieties
par: Alison Knopf
Publié: (2026)

Researchers urge slow tapers in deprescribing study for pediatrics
par: Alison Knopf
Publié: (2026)

ASAM releases new criteria for adolescents and youth
par: Alison Knopf
Publié: (2026)

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
par: Alison Knopf
Publié: (2026)

Patient Information Sheet
par: Alison Knopf
Publié: (2026)